Cardiac biomarkers of acute coronary syndrome: from history to high-sensitive cardiac troponin
- 346 Downloads
Acute coronary syndrome (CHD) represents a major cause of morbidity and mortality, accounting for more than 8 millions deaths in 2013 worldwide . Nevertheless, the mortality associated with CHD has fallen steeply in the past few decades reflecting, at least in part, the shift in the pattern of acute coronary syndrome (ACS), with the rise in non-ST-segment elevation ACS (NSTE-ACS) and a decline in ST-segment elevation myocardial infarction (STEMI), the latter accounting for approximately one-third of all ACS events . This shift in the last decade is basically due to a paradigmatic change in diagnostic testing with a widespread use of cardiac troponin assays, as well as to the change in the risk factor profile of patients with ACS . Cardiac troponin [both troponin I (cTnI) and T (cTnT)] assay] has become globally recognized as the preferred biomarker for diagnosing ACS, replacing all other laboratory tests, including creatine kinase (CK), CK MB, and myoglobin for its “absolute”...
KeywordsAcute Coronary Syndrome Acute Myocardial Infarction Acute Myocardial Infarction Cardiac Troponin Elevation Acute Coronary Syndrome
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
- 7.Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M et al (2013) Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med 51:1727–1737CrossRefPubMedGoogle Scholar
- 12.Möckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association (2016) Rule-in of acute myocardial infarction: focus on troponin. Eur Heart J Acute Cardiovasc Care. doi: 10.1177/2048872616653228
- 13.Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, TRAPID-AMI Investigators et al (2016) The use of very low concentrations of high-sensitivity troponin T to rule out acute myocardial infarction using a single blood test. Acad Emerg Med 23:1004–1013CrossRefPubMedGoogle Scholar
- 14.Mueller C, Giannitsis E, Christ M, Ordóñez-Llanos J, deFilippi C, McCord J, TRAPID-AMI Investigators et al (2016) Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 68(76–87):e4Google Scholar
- 15.Santi L, Farina G, Gramenzi A, Trevisani F, Baccini M, Bernardi M et al (2016) The HEART score with high-sensitive troponin T at presentation: ruling out patients with chest pain in the emergency room. Intern Emerg Med. doi: 10.1007/s11739-016-1461-3
- 18.Rostagno C, Cammilli A, Di Cristo A, Polidori GL, Ranalli C et al (2016) Acute coronary syndromes with significant troponin increase in patients with hip fracture prior to surgical repair: differential diagnosis and clinical implications. Intern Emerg Med 11(2):219–224. doi: 10.1007/s11739-015-1348-8 CrossRefPubMedGoogle Scholar